Amoxicillin is a semi-synthetic derivative of 6-aminopenicillanic acid (6-APA) that was developed by Beecham, England, during the 1960s. It is a widely used beta-lactam antibiotic belonging to the penicillin class and is prescribed for the treatment of a broad range of bacterial infections. These include infections caused by gram-positive bacteria, such as pneumonia, bronchitis, and gonorrhea, as well as infections affecting the ears, nose, throat, urinary tract, and skin. Amoxicillin is also effective against selected gram-negative bacterial infections.
Because amoxicillin is part of the penicillin group, it is recognized as a sensitizing agent that may trigger severe allergic reactions, including anaphylaxis, in susceptible individuals. As a result, dedicated manufacturing facilities and equipment are recommended to minimize the risk of cross-contamination. The report outlines qualitative formulations for amoxicillin dispersible tablets, including DisperMox® and Flemoxin Solutab®, and describes the functional role of excipients along with relevant limits from the US Food and Drug Administration (FDA) Inactive Ingredient Database (IID).
The report further explains that amoxicillin trihydrate dispersible tablets can be manufactured using a dry granulation process. It also discusses the required manufacturing equipment, the proposed production process, and scale-up considerations in accordance with the US FDA Scale Up and Post Approval Changes guidance for immediate-release formulations. In addition, the report covers pharmaceutical industry trends, manufacturing practices, plant planning, process engineering, project economics, and implementation considerations for establishing an amoxicillin manufacturing facility.
| Particular | Value |
|---|---|
| Plant Capacity | 3.2052 MT/Day |
| Land & Building (10,000 sq.mt.) | Rs. 18.07 Cr |
| Plant & Machinery | Rs. 3.50 Cr |
| Working Capital for 1 Month | Rs. 9.92 Cr |
| Total Capital Investment | Rs. 32.24 Cr |
| Rate of Return | 46% |
| Break Even Point | 42% |
Amoxicillin is a broad-spectrum penicillin-class antibiotic used to treat a variety of bacterial infections. It is commonly prescribed for respiratory tract infections, ear, nose and throat infections, urinary tract infections, skin infections, and certain infections caused by both gram-positive and selected gram-negative bacteria. As a beta-lactam antibiotic, it works by interfering with bacterial cell wall synthesis, helping eliminate susceptible bacteria when used according to appropriate medical guidelines.
Dedicated facilities are recommended to reduce the risk of cross-contamination. Amoxicillin belongs to the penicillin group, which can cause severe allergic reactions, including anaphylaxis, in sensitive individuals. Using dedicated equipment and manufacturing areas helps maintain product quality, supports regulatory compliance, and minimizes the possibility of contaminating other pharmaceutical products manufactured at the same site.
The report describes manufacturing amoxicillin trihydrate dispersible tablets using a dry granulation process. It outlines the required production equipment, process flow, formulation considerations, and scale-up recommendations. The manufacturing approach is intended to support consistent product quality while aligning with guidance for immediate-release pharmaceutical formulations.
The report provides a comprehensive overview of amoxicillin manufacturing, including chemical properties, synthesis routes, pharmaceutical industry analysis, manufacturing process, process flow diagrams, plant layout, utilities, safety considerations, plant location factors, project implementation schedules, supplier information, and financial appendices covering project economics and capital investment.
Successful plant planning depends on selecting a suitable location, ensuring reliable raw material availability, utilities, transportation, regulatory compliance, waste management, safety systems, and efficient plant layout. Proper equipment selection, storage design, material handling, and expansion planning also contribute to operational efficiency, product quality, and long-term project viability.
Scale-up guidance helps ensure that product quality remains consistent when manufacturing moves from development to commercial production. It addresses process consistency, equipment performance, validation, and regulatory expectations. Following recognized guidance reduces manufacturing risks and supports reliable production of pharmaceutical products at larger commercial volumes.
Detailed Project Report (DPR) includes Present Market Position and Expected Future Demand, Technology, Manufacturing Process, Investment Opportunity, Plant Economics and Project Financials. comprehensive analysis from industry covering detailed reporting and evaluates the position of the industry by providing insights to the SWOT analysis of the industry.
Each report include Plant Capacity, requirement of Land & Building, Plant & Machinery, Flow Sheet Diagram, Raw Materials detail with suppliers list, Total Capital Investment along with detailed calculation on Rate of Return, Break-Even Analysis and Profitability Analysis. The report also provides a birds eye view of the global industry with details on projected market size and then progresses to evaluate the industry in detail.
We can prepare detailed project report on any industry as per your requirement.
We can also modify the project capacity and project cost as per your requirement. If you are planning to start a business, contact us today.
EIRI Board is a single destination for all the industry, company and country reports. We feature a large repository of latest industry reports, leading and niche company profiles, and market statistics prepared by highly qualified consultants and verified by a panel of experts.
Note: We can also prepare project report on any subject based on your requirement and country. If you need, we can modify the project capacity and project cost based on your requirement.
Our reports provide an expansive market analysis of the sector by covering areas like growth drivers, trends prevailing in the industry as well as comprehensive SWOT analysis of the sector.
Speak with our experts and get personalized guidance for your manufacturing business idea, project planning, machinery selection, and investment strategy.